EMC Capital Management - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
EMC Capital Management ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$171
+4.3%
40,613
+886.7%
0.13%
-0.8%
Q2 2023$164
+192.9%
4,116
-89.9%
0.13%
+170.2%
Q1 2023$56
-30.9%
40,6130.0%0.05%
-35.6%
Q4 2022$81
-99.9%
40,6130.0%0.07%
-3.9%
Q3 2022$82,000
-36.4%
40,6130.0%0.08%
-30.9%
Q2 2022$129,000
-17.3%
40,613
+0.5%
0.11%
-1.8%
Q1 2022$156,00040,4170.11%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders